The ELISA for SCF (KITL) mouse test quantifyes the presence of mouse SCF in serum, plasma, or cell culture media. The dosage will only recognize natural and recombinant MS SCF. Method principle...
The ELISA for SCF (KITL) mouse test quantifyes the presence of mouse SCF in serum, plasma, or cell culture media. The dosage will only recognize natural and recombinant MS SCF. Principle of the method L-ELISA SCF solid phase sandwich for mice (enzymatic immunoassay) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Stem cell factor (SCF) is the c-Kit oncogen ligand and is expressed by various structural and inflammatory respiratory tract cells. The binding of CWS by the c-Kit receptor leads to homodimerization of the receptor and activation of signaling pathways such as PI-3, PLC-gamma, Jak/STAT and MAP kinase. The expression of CWS leads to the induction of mast cell survival and to the expression and release of histamine, pro-inflammatory cytokines and chemokines. Inhibition of the SCF/c-Kit pathway results in a decrease in the levels of d的histamine, mastocyte and eosinophil infiltration, production of LIL-4 and hyperreactivity of the respiratory tract, suggesting that this pathway can be a useful therapeutic target in inflammatory diseases such as asthma. There are at least two isoforms of CWS.
Sensitivity
Sensitivity of the dosage: 5 pg/ml.
Measurement range
Dose range: 2.74 to 2.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Sample volume: Plasma, 50 µl; serum, 50 µl; supernatant, 100 µl.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17125759 |
| Specifications |
| Accession number | 710-712; blz; c-Kit ligand; Clo ; cloud grey ; CON; contrast; CSF; DCUA; DFNA69; DKFZp686F2250; progressive family hyperpigmentation 2; FPH2; FPHH; Gb ; claw belly ; Hematopoietic growth factor KL; H-SCF; ligand kit; Kitl; Kitlg; Kit-ligand; KL-1; growth factor |
| Dose range | 2.74 to 2.000 pg/ml |
| Sensitivity of the dosage | 5 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P20826 |
| Gene symbol(s) | Kitl |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96-well pre-coated plate Standard Concentrate of dosing diluent Biotinylated detection antibody SAV-HRP Wash pad Chromogen Discontinue solution Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | SCF |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 µl; serum, 50 µl; supernatant, 100 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EMKITLX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.